{
    "title": "New brand-name HIV-prevention pill not worth the added cost - study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8093481/New-brand-HIV-prevention-pill-not-worth-added-cost--study.html",
    "date": "2020-03-09",
    "keywords": [
        "pill",
        "prep",
        "price",
        "drug",
        "risk",
        "study",
        "hiv",
        "prevention",
        "truvada",
        "descovy",
        "brandname",
        "cocktail",
        "medicine",
        "version",
        "kidney",
        "team",
        "email",
        "del",
        "rio",
        "rapaport",
        "health",
        "sale",
        "drop",
        "wont",
        "help",
        "preexposure",
        "prophylaxis",
        "day",
        "sex",
        "use",
        "patent",
        "year",
        "side",
        "damage",
        "rush",
        "transition",
        "lead",
        "author",
        "dr",
        "walensky",
        "hospital",
        "harvard",
        "school",
        "boston",
        "failure",
        "benefit",
        "opportunity",
        "injection",
        "budget",
        "person",
        "company",
        "comment",
        "difference",
        "effectiveness",
        "disease",
        "university",
        "atlanta",
        "editorial",
        "safety",
        "profile",
        "efficacy",
        "source",
        "httpsbitly3as2srn",
        "march"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}